A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

NL Cluny, VK Vemuri, AP Chambers, CL Limebeer, H Bedard, JT Wood, Beat Lutz, Andreas Zimmer, LA Parker, A. Makriyannis

British Journal of Pharmacology · 2010 · 189 citations · 48 references

DOIFull text

Open access

Abstract

Peripherally active, cannabinoid receptor antagonists with limited brain penetration may be useful agents for the treatment of obesity and its complications.

References

48